Pertussis toxin isolated from Bordetella pertussis phase I strain Tohama enhanced the migration of human blood monocytes in an assay with a multiwell chemotaxis assembly. The monocyte migration enhancement by pertussis toxin was abolished by heating at 100°C for 30 min, which caused a complete loss of the other biological activities of pertussis toxin. Checkerboard analysis demonstrated that the increased monocyte migration caused by pertussis toxin was directed toward a positive stimulus: chemotaxis. It is well known that the Bordetella pertussis phase I strain displays a variety of biological activities, including induction of lymphocytosis, histamine sensitization, and immunoadjuvant activities (13). The component responsible for these activities has been extensively investigated and is diversely referred to as the leukocytosis promoting factor (2, 9), the histamine-sensitizing factor (12), islets-activating protein (18) , and pertussigen (1) in different laboratories. To avoid confusion over the identity of this protein, the name pertussis toxin (PT), as proposed by Pittman (16), is used in this study.
taxis assembly.
The PT specimen used in this study was prepared by methods described previously (6) . Briefly, a culture supematant fluid of B. pertussis strain Tohama was passed twice through a hydroxylapatite column equilibrated with 0.01 M sodium phosphate buffer (pH 8) to remove filamentous hemagglutinin. The effluent from the second passage was adjusted to pH 6 with 6 N HCl and applied to a hydroxylapatite column equilibrated with 0.01 M sodium phosphate buffer (pH 6). The column was eluted with 0.1 M sodium phosphate-0.5 M sodium chloride buffer (pH 7). The PT contained in the effluent was further purified by chromatography with haptoglobin-Sepharose and Sepharose CL 6B columns. The purified toxin thus obtained gave a single band on polyacrylamide gel electrophoresis at pH 4 and five bands on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (10% gel). It had a molecular weight of 107,000 as judged by polyacrylamide gel electrophoresis at pH 4.0. When the preparation was injected intravenously into 4-week-old ddy mice, the minimum dose causing typical leukocytosis was 0.01 ,ug of toxin per animal.
The chemotactic assay was performed by a modified Boyden method (3) as described in previous reports (14, 15) . In brief, a cell fraction that consisted of 20% monocytes and 80% lymphocytes was obtained from heparinized venous blood drawn from healthy adult donors by a modification of the Ficoll-Hypaque method (4). This monocyte-enriched cell fraction was washed with phosphate-buffered saline (pH 7) and suspended at a density of 5 x 106 cells per ml in Gey balanced salt solution containing 2% bovine serum albumin (Sigma Chemical Co., St. Louis, Mo.) and 20 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (Sigma). The assays were performed in a multiwell chemotaxis assembly ( 
, and 80 ± 5 for lipopolysaccharide-activated serum (1:10) (A); that of a negative control was 18 ± 1. The asterisk indicates that results were significantly different from those obtained when a negative control was added with either a test or a reference specimen (P < 0.01).
passed through the filter was counted microscopically. The results were expressed as the mean ± standard error of the monocyte number (morphologically identified) per oil immersion field. N-Formyl-L-methionyl-L-leucyl-L-phenylalanine (Sigma) and lipopolysaccharide-activated human serum (14) were used as reference chemoattractants. Our assay system was never supplemented with complement components. Figure 1 shows that PT exhibited a significant dose-dependent enhancing effect on the migration of human peripheral monocytes at a concentration range of 0.01 to 10 ,ug/ml. The activity reached its maximum at 1 ,ug of PT per ml and decreased at a higher concentration (10 ,ug/ml). This enhancing activity of PT was completely destroyed when the toxin was heated at 100°C for 30 min, after which time the biological activities of the toxin, such as leukocytosis promotion and histamine sensitization, were lost (data not shown).
The observed enhancement of monocyte migration might be caused by chemotaxis directed by a concentration gradient of PT or by a mere increase in the migration rate of stimulated monocytes (chemokinesis). caused by an endotoxin-activated mouse serum, and that leukocytosis-promoting toxin alone did not exhibit chemotactic activity of those cells. The discrepancy between our findings and theirs may derive from the different cells tested; we used human peripheral monocytes, whereas they used murine macrophages. Utsumi et al. (17) isolated a factor from B. pertussis which inhibited the phagocytosis and chemotaxis of human polymorphonuclear leukocytes. We also noticed that PT stimulated the migration of polymorphonuclear leukocytes obtained from human peripheral blood (unpublished data).
Recently, we demonstrated that bacterial cell walls, peptidoglycans and their water-soluble components, and the synthetic muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine (5, 11), exhibited a definite chemotactic activity for human blood monocytes (14, 15) and that the chemotactic activity of the muramyl dipeptide was strictly dependent on its chemical structure. We have further shown that the lipid A moiety isolated from the endotoxic lipopolysaccharide of various gram-negative bacteria and some synthetic lipid A, namely acylated and phosphorylated derivatives of,B-1,6-glucosamine disaccharide, enhanced human monocyte migration (very likely through increased chemokinesis), whereas lipopolysaccharide specimens per se did not (S. Kotani Our results, together with the above-mentioned findings, indicate the importance of studies on the effects of bacterial cell (surface) components on monocytes, which are known to play an important role in either natural or acquired host defense mechanisms.
